Oko Okufanele Ukwazi Ngalo Mzimba Osebenzayo
Kwomntu onokubuyiselwa kwakhona-ukuyeka i- multiple sclerosis (i-RRMS) ejongene nokuphindaphinda okukhulu kweempawu, ukunyanga ukunyango ngokuqhelekileyo yi-corticosteroid. Lezi ziyobisi ezifanisa ihommoni eveliswa ngokwemvelo yi-adrenal glands ukukhupha ukuvuvukala (ubomvu, ukuvuvukala, intlungu). Kwimeko ye-MS kwakhona, i-corticosteroids inciphisa ukuvuvukala kwinkqubo yesantya ephakathi-ukuvuvukala okukhokelela kwiimpawu ze-MS ezinjengeentlungu zamehlo okanye iingxaki zombono , ubuthathaka bomzimba kunye neengxaki zokulinganisa.
Ngaba Uyakudinga i-Solu-Medrol?
Ngokuqhelekileyo, i-corticosteroid ekhethiweyo yokunyanga i-MS ehlaziyileyo yiyobisi ebizwa ngokuba yiSolu-Medrol (methylprednisolone). (Qaphela ukuba ngamanye amaxesha ugqirha uya kumisela le nkunkuma kumntu onomqondiso onjengeentlungu eziqhubeka ziba zibi nakwixesha elide, uye waqhubekela phambili kwinqanaba lokungaxolisi, kwaye akazange aphuculwe kunye nezinye izibonelelo.
I-Solu-Medrol yinyango enamandla, kwaye ayinayo imiphumo emibi, ngoko kubalulekile ukuba kuqiniseke ukuba kuyimfuneko. Umzekelo, kufuneka ukuba kucaciswe ukuba i-MS yangempela ibuyela kwakhona. Ukuba ucinga ukuba oko kwenzeka ntoni kuwe, nantsi ezinye izinto ozibuzeyo malunga noko uhlangabezana nazo. Ukuba uphendule ewe kule mibuzo, usenokuba nokuphindaphinda.
- Ngaba ndifumana iimpawu ezintsha okanye iimpawu endingazibi kakhulu?
- Ngaba oku kwenzeke ngaphezu kweeyure ezingama-24 ukuya kwiintsuku ezimbalwa?
- Ngaba le miqondiso idlule iiyure ezingama-24?
- Ingaba kukho ubuncinane inyanga ukususela kwam wokugqibela kwakhona? (Ngamanye amazwi, ngaba le mpawu ayikho okanye izinzile ubuncinane iintsuku ezingama-30 ngaphambi kokuba zivele okanye zibi?)
Ukuqinisekisa ukuba unobungozi okanye ukuyilawula, ugqirha wakho angenza i-MRI. Kubonakala ukuba abantu abaninzi abane-MS, ingakumbi kulawo mazinga okuqala e-RRMS, banemilenze embalwa emininzi eyenzekayo ngexesha lonke.
Lezi zilonda "ezikhanyayo" phambi kwe-gadolinium (i-ejensi eyahlukileyo esetyenziselwa i-MRI scans) malunga neveki ezintandathu, ize iphele njengoko ukuvuvukala kuhamba. Xa i-MRI ibonisa ezimbalwa izilonda ezinjalo zibangalisa iimpawu, kwaye ngokuqinisekileyo ayibangeli iimpawu ezinzima ngokwaneleyo ukusebenzisa igama elithi "ukuphindaphinda" kwimeko, uSolu-Medrol mhlawumbi ayifuni.
Ukuthatha iSolu-Medrol
Xa la mayeza enikwa ukuphathwa kwe-MS kwakhona, ngokuqhelekileyo kunikwa ngenyameko-oko kukuthi, ngokusebenzisa inaliti ngqo kwi-vein-phezu kwexesha leentsuku ezintathu ukuya ezintlanu. Kubantu abaninzi, iSolu-Medrol inokuzisa inani elikhulu lokukhululeka ekubuyiselweni kwakhona. Abanye baye bafumanisa ukuba emva kokunciphisa omnye kweziyobisi, iimpawu ze-MS eziphosakeleyo zikwazi ukulawulwa, okanye zinyamalale ngokupheleleyo. Okona kuncinci, kwiintsuku ezimbini okanye ezintathu zekhosi yeSolu-Medrol abaninzi abantu babika ukuba iimpawu zabo zibhetele ngakumbi.
Kungakhathaliseki ukuba isetyenziselwa ntoni, iSolu-Medrol ayinayo imiphumo emibi, njengeengxaki zesini kunye nokufumana ubunzima, ngoko ngamanye amaxesha kungcono ukuba ulinde ukuphindeka kwakhona (ukuba unako ukunyamezela iimpawu okanye ukufumana uncedo olunye unyango ). Ngokungathathi iSolu-Medrol awuyi kuba sengozini yomonakalo osisigxina okanye iziphumo ezishiyekileyo zamasosha ngokusebenzisa ukuphinda ubuyeke, kwaye uya kuphepha iziphumo ezibi.
Ungaphinda ubuze ugqirha wakho malunga nokuthatha i-Solu-Medrol kwifom yefayile, kunokuba i-infusion, engayinqumla kwimiphumo emibi. Kukho uphando lokuqala ukubonisa ukuba umlomo we-methylprednisolone unokusebenza ngendlela efanelekileyo ekunciphiseni i-MS kwakhona njengesifo somngcipheko.
> Imithombo:
> E le Page, et al. "Ukusebenza kunye noKhuselo lweMlomo kunye noThutho oluphezulu lweMethylprednisolone kwi-Multiple Sclerosis, i-Trial-Blind Trial (COPOUSEP)." Lancet . 2015 Septemba 5; 386 (9997): 974-81.
> Olek MJ. "Unyango lweZiphumo ezixakekileyo ze-Multiple Sclerosis kubantu abadala." UpToDate 2016.
> Ontaneda D & Rae-Grant AD. Ulawulo lweeNgqungquthela ezixakekileyo kwi-Multiple Sclerosis. Ann Indian Acad Neurol . 2009 Oct; 12 (4): 264-7.